# Aenova expands sterile fill & finish capacity at Latina site with €100M investment

Aenova announces a major investment in its sterile manufacturing capabilities with the installation of another fill & finish line at its Latina site. The investment is approximately €100 million over three years, adding annual capacity of 30-40 million units. Construction is underway, equipment installation planned for 2026, and GMP manufacturing start in Q3 2027.

- Type: Expansion
- Announced: 2025-10-23
- Where: Latina, Italy, Italy
- Value: $109.0M (100.0M EUR)
- Starts operating: Q3 2027
- Status: under construction
- Capacity: 30-40 million units per year
- Products: biologics, monoclonal antibodies, peptides, vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Aenova Group](https://endata.com/companies/88010.md)

## Sources

- [aenova-group.com](https://www.aenova-group.com/en/news-events/news/aenova-expands-sterile-fill-finish-manufacturing-capacity-at-its-latina-site), 2025-10-23: "The new fill & finish line will support a broad range of container formats, including vials ranging from 2R to 50R, pre-filled syringes from 0.5mL to 50mL, and pre-filled cartridges from 1mL to 20mL."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.